 |
Hikma signs licence agreement for molnupiravirHikma Pharmaceuticals, the multinational pharmaceutical company, announces that it has entered into a licence agreement with Medicine Patent Pool (MPP) for molnupiravir, MSD’s investigational oral Covid-19 antiviral medicine, in the Midd More… |
 |
MSD inaugurates newly redesigned GCC headquartersMSD, a leading global pharmaceutical company, has inaugurated its newly redesigned regional headquarters, which seeks to deliver an activity-based workplace that brings to life the firm’s new Ways of Working philosophy. More… |
|
MSD inaugurates newly redesigned GCC headquartersMSD, a leading global pharmaceutical company, has inaugurated its newly redesigned regional headquarters, which seeks to deliver an activity-based workplace that brings to life the firm’s new Ways of Working philosophy. More… |
 |
MSD appoints new Managing Director for GCCMSD, a leading global pharmaceutical company, has appointed Ashraf Malak as the Managing Director for the Gulf Cooperation Council cluster which includes Saudi Arabia, the UAE, Kuwait, Bahrain, Qatar and Oman. More… |
 |
MSD highlights cholesterol-cardiac relationshipMSD, a leading global biopharmaceutical company, recently held an event with regional medical professionals to focus on the relationship between cholesterol and cardiovascular diseases across Saudi Arabia, and the wider region. Du More… |
 |
Cervical cancer focus for MSD forumMSD, a leading global biopharmaceutical company, recently hosted a round-table in Dubai,UAE to address the rising issue of the Human Papillomavirus (HPV) and the increasing risk of cervical cancer in the Mena region. The event, at More… |
 |
Julphar-MSD partnership wins top ASAP awardJulphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa (MEA), has won the Association of Strategic Alliance Professionals (ASAP) award for 2018 along with its alliance partner, MSD. MSD (known More… |
 |
MSD unveils new resources for diabetes patientsMSD, known as Merck in the US and Canada, has launched new interactive and educational resources to help people with type 2 diabetes in the Middle East who choose to fast during Ramadan. ‘The Facts About Fasting Durin More… |
 |
Julphar in deal to produce, market MSD drugsMSD, a global healthcare firm, and Julphar, a UAE-based pharmaceutical company, have signed a five-year agreement, which provides Julphar with exclusive rights to produce, market, distribute and sell certain MSD medicines in the region. More… |
|
Julphar in deal to produce, market MSD drugsMSD, a global healthcare firm, and Julphar, a UAE-based pharmaceutical company, have signed a five-year agreement, which provides Julphar with exclusive rights to produce, market, distribute and sell certain MSD medicines in the region. More… |
